Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Gastric Cancer

Free Subscription Articles published in Cancer Lett Retrieve available abstracts of 60 articles: HTML format

Single Articles

April 2024
1. ZHANG J, Fu L, Wang H, Yonemura A, et al
   RAC1-mediated Integrin alpha-6 expression in E-cadherin-deficient gastric cancer cells promotes interactions with the stroma and peritoneal dissemination.
   Cancer Lett. 2024 Apr 17:216901. doi: 10.1016/j.canlet.2024.216901.
   PubMed     Abstract available
   
   
   
2. CHEN J, Ji Y, Liu Y, Cen Z, et al
   Exhaled volatolomics profiling facilitates personalized screening for gastric cancer.
   Cancer Lett. 2024;590:216881.
   PubMed     Abstract available
   
   
   
3. WANG L, Mao X, Yu X, Su J, et al
   FPR3 reprograms glycolytic metabolism and stemness in gastric cancer via calcium-NFATc1 pathway.
   Cancer Lett. 2024 Apr 11:216841. doi: 10.1016/j.canlet.2024.216841.
   PubMed     Abstract available
   
   
   
4. ZHANG Y, Lin W, Yang Y, Zhu S, et al
   MEF2D facilitates liver metastasis of gastric cancer cells through directly inducing H1X under IL-13 stimulation.
   Cancer Lett. 2024 Apr 10:216878. doi: 10.1016/j.canlet.2024.216878.
   PubMed     Abstract available
   
   
   
5. WEN W, Ertas YN, Erdem A, Zhang Y, et al
   Dysregulation of autophagy in gastric carcinoma: Pathways to tumor progression and resistance to therapy.
   Cancer Lett. 2024 Apr 5:216857. doi: 10.1016/j.canlet.2024.216857.
   PubMed     Abstract available
   
   
   March 2024
6. RIEGEL G, Orvain C, Recberlik S, Spaety ME, et al
   The unfolded protein response-glutathione metabolism axis: A novel target of a cycloruthenated complexes bypassing tumor resistance mechanisms.
   Cancer Lett. 2024;585:216671.
   PubMed     Abstract available
   
   
   
7. ZHAO Z, Cai Z, Zhang S, Yin X, et al
   Activation of the FOXM1/ASF1B/PRDX3 axis confers hyperproliferative and antioxidative stress reactivity to gastric cancer.
   Cancer Lett. 2024 Mar 25:216796. doi: 10.1016/j.canlet.2024.216796.
   PubMed     Abstract available
   
   
   February 2024
8. CHANG M, Sun Q, Cui X, Wang Y, et al
   Lnc-PLCB1 is stabilized by METTL14 induced m6A modification and inhibits Helicobacter pylori mediated gastric cancer by destabilizing DDX21.
   Cancer Lett. 2024 Feb 20:216746. doi: 10.1016/j.canlet.2024.216746.
   PubMed     Abstract available
   
   
   
9. LIN C, Lin P, Yao H, Liu S, et al
   Modulation of YBX1-mediated PANoptosis inhibition by PPM1B and USP10 confers chemoresistance to oxaliplatin in gastric cancer.
   Cancer Lett. 2024 Feb 14:216712. doi: 10.1016/j.canlet.2024.216712.
   PubMed     Abstract available
   
   
   
10. LIANG B, Wu Q, Wang Y, Shi Y, et al
    Cdc42-driven endosomal cholesterol transport promotes collateral resistance in HER2-positive gastric cancer.
    Cancer Lett. 2024 Feb 7:216702. doi: 10.1016/j.canlet.2024.216702.
    PubMed     Abstract available
    
    
    January 2024
11. CHEN P, Zhong X, Song Y, Zhong W, et al
    Triptolide induces apoptosis and cytoprotective autophagy by ROS accumulation via directly targeting peroxiredoxin 2 in gastric cancer cells.
    Cancer Lett. 2024 Jan 19:216622. doi: 10.1016/j.canlet.2024.216622.
    PubMed     Abstract available
    
    
    
12. WU QN, Qi J, Liu ZK, Luo XJ, et al
    HIPK3 maintains sensitivity to platinum drugs and prevents disease progression in gastric cancer.
    Cancer Lett. 2024 Jan 19:216643. doi: 10.1016/j.canlet.2024.216643.
    PubMed     Abstract available
    
    
    
13. WENG N, Zhou C, Zhou Y, Zhong Y, et al
    IKZF4/NONO-RAB11FIP3 axis promotes immune evasion in gastric cancer via facilitating PD-L1 endosome recycling.
    Cancer Lett. 2024 Jan 9:216618. doi: 10.1016/j.canlet.2024.216618.
    PubMed     Abstract available
    
    
    November 2023
14. WANG H, Zhou Z, Zhang J, Hao T, et al
    Pumilio1 regulates NPM3/NPM1 axis to promote PD-L1-mediated immune escape in gastric cancer.
    Cancer Lett. 2023;581:216498.
    PubMed     Abstract available
    
    
    
15. JIANG T, Xia Y, Li Y, Lu C, et al
    TRIM29 promotes antitumor immunity through enhancing IGF2BP1 ubiquitination and subsequent PD-L1 downregulation in gastric cancer.
    Cancer Lett. 2023;581:216510.
    PubMed     Abstract available
    
    
    October 2023
16. FENG W, Ma C, Rao H, Zhang W, et al
    Setd2 deficiency promotes gastric tumorigenesis through inhibiting the SIRT1/FOXO pathway.
    Cancer Lett. 2023 Oct 30:216470. doi: 10.1016/j.canlet.2023.216470.
    PubMed     Abstract available
    
    
    
17. HUA H, Su T, Han L, Zhang L, et al
    LINC01226 promotes gastric cancer progression through enhancing cytoplasm-to-nucleus translocation of STIP1 and stabilizing beta-catenin protein.
    Cancer Lett. 2023 Oct 6:216436. doi: 10.1016/j.canlet.2023.216436.
    PubMed     Abstract available
    
    
    September 2023
18. LI J, Feng H, Zhu J, Yang K, et al
    Gastric cancer derived exosomal THBS1 enhanced Vgamma9Vdelta2 T-cell function through activating RIG-I-like receptor signaling pathway in a N6-methyladenosine methylation dependent manner.
    Cancer Lett. 2023 Sep 30:216410. doi: 10.1016/j.canlet.2023.216410.
    PubMed     Abstract available
    
    
    August 2023
19. MAO D, Zhou Z, Chen H, Liu X, et al
    Pleckstrin-2 promotes tumour immune escape from NK cells by activating the MT1-MMP-MICA signalling axis in gastric cancer.
    Cancer Lett. 2023 Aug 15:216351. doi: 10.1016/j.canlet.2023.216351.
    PubMed     Abstract available
    
    
    
20. ANDREUCCI E, Biagioni A, Peri S, Versienti G, et al
    The CAIX inhibitor SLC-0111 exerts anti-cancer activity on gastric cancer cell lines and resensitizes resistant cells to 5-Fluorouracil, taxane-derived, and platinum-based drugs.
    Cancer Lett. 2023 Aug 5:216338. doi: 10.1016/j.canlet.2023.216338.
    PubMed     Abstract available
    
    
    July 2023
21. ZHAO P, Yuan F, Xu L, Jin Z, et al
    HKDC1 reprograms lipid metabolism to enhance gastric cancer metastasis and cisplatin resistance via forming a ribonucleoprotein complex.
    Cancer Lett. 2023 Jul 7:216305. doi: 10.1016/j.canlet.2023.216305.
    PubMed     Abstract available
    
    
    May 2023
22. CHEN Z, Xu P, Wang X, Li Y, et al
    MSC-NPRA loop drives fatty acid oxidation to promote stemness and chemoresistance of gastric cancer.
    Cancer Lett. 2023;565:216235.
    PubMed     Abstract available
    
    
    April 2023
23. LI M, Mei YX, Wen JH, Jiao YR, et al
    Hepatoid adenocarcinoma-Clinicopathological features and molecular characteristics.
    Cancer Lett. 2023;559:216104.
    PubMed     Abstract available
    
    
    February 2023
24. YANG J, Xu P, Chen Z, Zhang X, et al
    N6-methyadenosine modified SUV39H2 regulates homologous recombination through epigenetic repression of DUSP6 in gastric cancer.
    Cancer Lett. 2023;558:216092.
    PubMed     Abstract available
    
    
    December 2022
25. CHEN T, Chen J, Zeng T, Huang Q, et al
    WZ35 inhibits gastric cancer cell metastasis by depleting glutathione to promote cellular metabolic remodeling.
    Cancer Lett. 2022 Dec 24:216044. doi: 10.1016/j.canlet.2022.216044.
    PubMed     Abstract available
    
    
    
26. ZHENG W, Yang Z, Song P, Sun Y, et al
    SHP2 inhibition mitigates adaptive resistance to MEK inhibitors in KRAS-mutant gastric cancer through the suppression of KSR1 activity.
    Cancer Lett. 2022 Dec 6:216029. doi: 10.1016/j.canlet.2022.216029.
    PubMed     Abstract available
    
    
    November 2022
27. XU Y, Lu J, Tang Y, Xie W, et al
    Retraction notice to "PINK1 deficiency in gastric cancer compromises mitophagy, promotes the Warburg effect, and facilitates M2 polarization of macrophages" [Cancer Lett. 529 (2022) 19-36].
    Cancer Lett. 2022;549:215931.
    PubMed     Abstract available
    
    
    October 2022
28. YONG X, Tang B, Xiao YF, Xie R, et al
    Corrigendum to "Helicobacter pylori upregulates Nanog and Oct4 via Wnt/beta-catenin signaling pathway to promote cancer stem cell-like properties in human gastric cancer" [Canc. Lett. 374 (2016) 292-303].
    Cancer Lett. 2022 Oct 21:215961. doi: 10.1016/j.canlet.2022.215961.
    PubMed    
    
    
    September 2022
29. WANG S, Wo L, Zhang Z, Zhu C, et al
    Delivery of LINC00589 via mesoporous silica nanoparticles inhibits peritoneal metastasis in gastric cancer.
    Cancer Lett. 2022 Sep 17:215916. doi: 10.1016/j.canlet.2022.215916.
    PubMed     Abstract available
    
    
    August 2022
30. ZHANG JY, Du Y, Gong LP, Shao YT, et al
    Corrigendum to "ebv-circRPMS1 promotes the progression of EBV-associated gastric carcinoma via Sam68-dependent activation of METTL3 [Cancer Letters 535 (2022) 215646]''.
    Cancer Lett. 2022 Aug 4:215824. doi: 10.1016/j.canlet.2022.215824.
    PubMed    
    
    
    July 2022
31. HE D, Chen M, Chang L, Gu J, et al
    De novo pyrimidine synthesis fuels glycolysis and confers chemoresistance in gastric cancer.
    Cancer Lett. 2022 Jul 31:215837. doi: 10.1016/j.canlet.2022.215837.
    PubMed     Abstract available
    
    
    
32. WANG M, Cai W, Yang AJ, Wang CY, et al
    Gastric cancer cell-derived extracellular vesicles disrupt endothelial integrity and promote metastasis.
    Cancer Lett. 2022 Jul 13:215827. doi: 10.1016/j.canlet.2022.215827.
    PubMed     Abstract available
    
    
    
33. HU F, Peng Y, Chang S, Luo X, et al
    Vimentin binds to a novel tumor suppressor protein, GSPT1-238aa, encoded by circGSPT1 with a selective encoding priority to halt autophagy in gastric carcinoma.
    Cancer Lett. 2022 Jul 12:215826. doi: 10.1016/j.canlet.2022.215826.
    PubMed     Abstract available
    
    
    June 2022
34. ZENG S, Xie X, Xiao YF, Tang B, et al
    Corrigendum to "Long noncoding RNA LINC00675 enhances phosphorylation of vimentin on Ser83 to suppress gastric cancer progression" [Cancer Lett. 2018 Jan 1;412:179-187].
    Cancer Lett. 2022 Jun 24:215805. doi: 10.1016/j.canlet.2022.215805.
    PubMed    
    
    
    
35. HONG YH, Aziz N, Park JG, Lee D, et al
    The EEF1AKMT3/MAP2K7/TP53 axis suppresses tumor invasiveness and metastasis in gastric cancer.
    Cancer Lett. 2022;544:215803.
    PubMed     Abstract available
    
    
    May 2022
36. HE J, Hu W, Ouyang Q, Zhang S, et al
    Helicobacter pylori infection induces stem cell-like properties in Correa cascade of gastric cancer.
    Cancer Lett. 2022 May 30:215764. doi: 10.1016/j.canlet.2022.215764.
    PubMed     Abstract available
    
    
    April 2022
37. LIU X, Lu Y, Xu Y, Hou S, et al
    Corrigendum to "Exosomal transfer of miR-501 confers doxorubicin resistance and tumorigenesis via targeting of BLID in gastric cancer" [Canc. Lett. 459 (2019 Sep 10) 122-134].
    Cancer Lett. 2022 Apr 29:215695. doi: 10.1016/j.canlet.2022.215695.
    PubMed    
    
    
    
38. YAMADA H, Takeshima H, Fujiki R, Yamashita S, et al
    ARID1A loss-of-function induces CpG island methylator phenotype.
    Cancer Lett. 2022;532:215587.
    PubMed     Abstract available
    
    
    
39. CHEN T, Jinlin D, Wang F, Yuan Z, et al
    GSTM3 deficiency impedes DNA mismatch repair to promote gastric tumorigenesis via CAND1/NRF2-KEAP1 signaling.
    Cancer Lett. 2022 Apr 26:215692. doi: 10.1016/j.canlet.2022.215692.
    PubMed     Abstract available
    
    
    March 2022
40. ZHANG JY, Du Y, Gong LP, Shao YT, et al
    ebv-circRPMS1 promotes the progression of EBV-associated gastric carcinoma via Sam68-dependent activation of METTL3.
    Cancer Lett. 2022;535:215646.
    PubMed     Abstract available
    
    
    February 2022
41. ZHOU X, Fang D, Liu H, Ou X, et al
    PMN-MDSCs accumulation induced by CXCL1 promotes CD8(+) T cells exhaustion in gastric cancer.
    Cancer Lett. 2022 Feb 14:215598. doi: 10.1016/j.canlet.2022.215598.
    PubMed     Abstract available
    
    
    December 2021
42. XU Y, Lu J, Tang Y, Xie W, et al
    PINK1 deficiency in gastric cancer compromises mitophagy, promotes the Warburg effect, and facilitates M2 polarization of macrophages.
    Cancer Lett. 2021;529:19-36.
    PubMed     Abstract available
    
    
    
43. DU Y, Zhang JY, Gong LP, Feng ZY, et al
    Hypoxia-induced ebv-circLMP2A promotes angiogenesis in EBV-associated gastric carcinoma through the KHSRP/VHL/HIF1alpha/VEGFA pathway.
    Cancer Lett. 2021 Dec 1. pii: S0304-3835(21)00605.
    PubMed     Abstract available
    
    
    November 2021
44. MIYAMOTO S, Nagano Y, Miyazaki M, Nagamura Y, et al
    Integrin alpha5 mediates cancer cell-fibroblast adhesion and peritoneal dissemination of diffuse-type gastric carcinoma.
    Cancer Lett. 2021 Nov 12. pii: S0304-3835(21)00575.
    PubMed     Abstract available
    
    
    
45. LI ZY, Xie Y, Deng M, Zhu L, et al
    c-Myc-activated intronic miR-210 and lncRNA MIR210HG synergistically promote the metastasis of gastric cancer.
    Cancer Lett. 2021 Nov 9. pii: S0304-3835(21)00572.
    PubMed     Abstract available
    
    
    October 2021
46. ZHANG H, Ma RR, Zhang G, DongYi, et al
    Long noncoding RNA lnc-LEMGC combines with DNA-PKcs to suppress gastric cancer metastasis.
    Cancer Lett. 2021 Oct 6. pii: S0304-3835(21)00503.
    PubMed     Abstract available
    
    
    September 2021
47. DAI W, Liu S, Zhang J, Pei M, et al
    Vorinostat triggers miR-769-5p/3p-mediated suppression of proliferation and induces apoptosis via the STAT3-IGF1R-HDAC3 complex in human gastric cancer.
    Cancer Lett. 2021 Sep 2. pii: S0304-3835(21)00437.
    PubMed     Abstract available
    
    
    August 2021
48. SUGIMOTO A, Okuno T, Miki Y, Tsujio G, et al
    EMMPRIN in extracellular vesicles from peritoneal mesothelial cells stimulates the invasion activity of diffuse-type gastric cancer cells.
    Cancer Lett. 2021 Aug 30. pii: S0304-3835(21)00428.
    PubMed     Abstract available
    
    
    
49. JIANG L, Chen Y, Min G, Wang J, et al
    Bcl2-associated athanogene 4 promotes the invasion and metastasis of gastric cancer cells by activating the PI3K/AKT/NF-kappaB/ZEB1 axis.
    Cancer Lett. 2021 Aug 19. pii: S0304-3835(21)00409.
    PubMed     Abstract available
    
    
    July 2021
50. LIN DC, Zheng SY, Zhang ZG, Luo JH, et al
    TRPC3 promotes tumorigenesis of gastric cancer via the CNB2/GSK3beta/NFATc2 signaling pathway.
    Cancer Lett. 2021 Jul 23. pii: S0304-3835(21)00370.
    PubMed     Abstract available
    
    
    June 2021
51. KOH V, Chakrabarti J, Torvund M, Steele N, et al
    Hedgehog transcriptional effector GLI mediates mTOR-Induced PD-L1 expression in gastric cancer organoids.
    Cancer Lett. 2021 Jun 11. pii: S0304-3835(21)00292.
    PubMed     Abstract available
    
    
    
52. CHEN Y, Li Y, Qi C, Zhang C, et al
    Dysregulated KRAS gene-signaling axis and abnormal chromatin remodeling drive therapeutic resistance in heterogeneous-sized circulating tumor cells in gastric cancer patients.
    Cancer Lett. 2021;517:78-87.
    PubMed     Abstract available
    
    
    
53. MILIOTIS C, Slack FJ
    miR-105-5p regulates PD-L1 expression and tumor immunogenicity in gastric cancer.
    Cancer Lett. 2021 Jun 4. pii: S0304-3835(21)00268.
    PubMed     Abstract available
    
    
    December 2020
54. DAVERN M, Lysaght J
    Cooperation between chemotherapy and immunotherapy in gastroesophageal cancers.
    Cancer Lett. 2020;495:89-99.
    PubMed     Abstract available
    
    
    October 2020
55. ZHU S, Khalafi S, Chen Z, Poveda J, et al
    Silencing of miR490-3p by H. pylori activates DARPP-32 and induces resistance to gefitinib.
    Cancer Lett. 2020;491:87-96.
    PubMed     Abstract available
    
    
    
56. TANG H, Kong Y, Guo J, Tang Y, et al
    Corrigendum to "Diallyl disulfide suppresses proliferation and induces apoptosis in human gastric cancer through Wnt-1 signaling pathway by up-regulation of miR-200b and miR-22" [Canc. Lett. 340 (1) (Oct 28, 2013) 72-81].
    Cancer Lett. 2020 Oct 5. pii: S0304-3835(20)30356.
    PubMed    
    
    
    September 2020
57. YANG J, Liu Z, Zeng B, Hu G, et al
    Epstein-Barr virus-associated gastric cancer: A distinct subtype.
    Cancer Lett. 2020 Sep 23. pii: S0304-3835(20)30486.
    PubMed     Abstract available
    
    
    
58. MA DH, Li BS, Liu JJ, Xiao YF, et al
    Corrigendum to 'miR-93-5p/IFNAR1 axis promotes gastric cancer metastasis through activating the STAT3 signaling pathway'[Cancer Lett. 2017 Nov 1;408:23-32].
    Cancer Lett. 2020 Sep 22. pii: S0304-3835(20)30470.
    PubMed    
    
    
    March 2020
59. WANG Y, Lu JH, Wang F, Wang YN, et al
    Inhibition of fatty acid catabolism augments the efficacy of oxaliplatin-based chemotherapy in gastrointestinal cancers.
    Cancer Lett. 2020;473:74-89.
    PubMed     Abstract available
    
    
    
60. TAM BY, Chiu K, Chung H, Bossard C, et al
    The CLK inhibitor SM08502 induces anti-tumor activity and reduces Wnt pathway gene expression in gastrointestinal cancer models.
    Cancer Lett. 2020;473:186-197.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Gastric Cancer is free of charge.